Income Statement Ameriprise Financial, Inc.

Equities

AMP

US03076C1062

Investment Management & Fund Operators

Market Closed - Nyse Other stock markets 21:00:02 08/05/2026 BST			5-day change	1st Jan Change
465.56 ^USD	+1.46%		-0.35%	-5.05%

05-04	Piper Sandler Adjusts Price Target on Ameriprise Financial to $471 From $460, Maintains Neutral Rating	MT
05-04	Argus Adjusts Price Target on Ameriprise Financial to $534 From $554, Maintains Buy Rating	MT

a4.wfxbh-W_nKk0hOhxkx9XFpkL_maioYkHmpPMIRbAt4I.pckTzYfo8-J3_ZkSoy4bdNImnwzq1ex37ae0U3yL78iIiQH3iO-twWXOpQ

Published financial data: AMERIPRISE FINANCIAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	11.38B	12.38B	12.38B	13.76B	14.81B
Interest And Invest. Income (Rev)	1.68B	1.47B	3.21B	3.65B	3.57B
Other Revenues, Total	382M	491M	513M	516M	528M
Total Revenues	13.44B	14.35B	16.1B	17.93B	18.91B
Cost of Goods Sold, Total	5.86B	6.5B	6.67B	7.56B	8.29B
Gross Profit	7.59B	7.84B	9.42B	10.36B	10.62B
Selling General & Admin Expenses, Total	3.4B	3.67B	3.81B	3.9B	3.88B
Other Operating Expenses, Total	3.4B	3.67B	3.81B	3.9B	3.88B
Operating Income	4.18B	4.17B	5.61B	6.46B	6.75B
Interest Expense, Total	-803M	-939M	-1.54B	-1.61B	-1.23B
Net Interest Expenses	-803M	-939M	-1.54B	-1.61B	-1.23B
Other Non Operating Income (Expenses)	-	-	-778M	-584M	-1.01B
EBT, Excl. Unusual Items	3.38B	3.23B	3.3B	4.27B	4.5B
Merger & Related Restructuring Charges	-32M	-50M	-62M	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Legal Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	3.35B	3.18B	3.23B	4.27B	4.5B
Income Tax Expense	590M	623M	678M	866M	941M
Earnings From Continuing Operations	2.76B	2.56B	2.56B	3.4B	3.56B
Net Income to Company	2.76B	2.56B	2.56B	3.4B	3.56B
Net Income - (IS)	2.76B	2.56B	2.56B	3.4B	3.56B
Net Income to Common Incl Extra Items	2.76B	2.56B	2.56B	3.4B	3.56B
Net Income to Common Excl. Extra Items	2.76B	2.56B	2.56B	3.4B	3.56B
Per Share Items
Net EPS - Basic	23.53	22.99	24.18	33.67	36.85
Basic EPS - Continuing Operations	23.53	22.99	24.18	33.67	36.85
Basic Weighted Average Shares Outstanding	117M	111M	106M	101M	96.7M
Net EPS - Diluted	23	22.51	23.71	33.05	36.28
Diluted EPS - Continuing Operations	23	22.51	23.71	33.05	36.28
Diluted Weighted Average Shares Outstanding	120M	114M	108M	103M	98.2M
Normalized Basic EPS	18.02	18.15	19.49	26.4	29.11
Normalized Diluted EPS	17.61	17.77	19.11	25.92	28.67
Dividend Per Share	4.43	4.88	5.3	5.79	6.28
Payout Ratio	18.51	20.87	21.52	16.88	16.73
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	4.28B	4.27B	-	-	-
EBITA	4.22B	4.22B	5.66B	6.51B	6.81B
EBIT	4.18B	4.17B	5.61B	6.46B	6.75B
EBITDAR	4.34B	4.33B	-	-	-
Total Revenues (As Reported)	13.44B	14.35B	16.1B	17.93B	18.91B
Effective Tax Rate - (Ratio)	17.61	19.58	20.96	20.3	20.89
Current Domestic Taxes	630M	602M	642M	720M	759M
Current Foreign Taxes	47M	25M	18M	21M	25M
Total Current Taxes	677M	627M	660M	741M	784M
Deferred Domestic Taxes	-65M	2M	31M	135M	155M
Deferred Foreign Taxes	-22M	-6M	-13M	-10M	2M
Total Deferred Taxes	-87M	-4M	18M	125M	157M
Normalized Net Income	2.11B	2.02B	2.06B	2.67B	2.82B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	2M	1M	1M	1M	-
Non-Cash Pension Expense	-10M	-11M	-9M	-13M	-15M
Supplemental Operating Expense Items
General and Administrative Expenses	3.35B	3.61B	3.75B	3.84B	3.81B
Net Rental Expense, Total	57M	61M	55M	61M	62M
Imputed Operating Lease Interest Expense	93.17M	122M	171M	198M	164M
Imputed Operating Lease Depreciation	-36.17M	-60.63M	-116M	-137M	-102M
Stock-Based Comp., G&A Exp. (Total)	244M	214M	249M	251M	241M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	244M	214M	249M	251M	241M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.13B	6.96B	7.48B	8.15B	9.95B
Trading Asset Securities, Total	1.25B	267M	185M	-	143M
Total Cash And Short Term Investments	8.38B	7.23B	7.66B	8.15B	10.1B
Accounts Receivable, Total	16.2B	15.78B	15.08B	14.47B	14.92B
Total Receivables	16.2B	15.78B	15.08B	14.47B	14.92B
Restricted Cash	2.8B	2.23B	1.06B	967M	1.06B
Other Current Assets, Total	4.46B	2.91B	5.18B	9.46B	13.16B
Total Current Assets	31.84B	28.14B	28.97B	33.05B	39.23B
Gross Property Plant And Equipment	2.92B	2.83B	2.86B	2.99B	2.97B
Accumulated Depreciation	-2B	-1.9B	-1.9B	-2B	-2B
Net Property Plant And Equipment	919M	926M	958M	987M	967M
Long-term Investments	32.71B	41.22B	53.99B	54.92B	56.71B
Goodwill	1.46B	1.39B	1.41B	1.4B	1.44B
Other Intangibles, Total	1.11B	1.1B	1.21B	1.17B	1.16B
Deferred Tax Assets Long-Term	1.09B	1.7B	1.43B	1.33B	920M
Deferred Charges Long-Term	3.1B	3.47B	2.85B	2.82B	2.78B
Other Long-Term Assets, Total	104B	80.52B	84.38B	85.72B	87.71B
Total Assets	176B	158B	175B	181B	191B
Liabilities
Accounts Payable, Total	2.53B	2.24B	2.6B	2.7B	2.98B
Accrued Expenses, Total	5M	12M	-	-	-
Short-term Borrowings	200M	201M	201M	201M	200M
Current Portion of Long-Term Debt	468M	1.1B	855M	824M	719M
Current Portion of Leases	79M	80M	79M	81M	68M
Unearned Revenue Current, Total	-	-	-	-	187M
Other Current Liabilities	6.61B	3.65B	5.52B	8.9B	12.98B
Total Current Liabilities	9.89B	7.29B	9.26B	12.7B	17.13B
Long-Term Debt	2.79B	2.04B	2.83B	2.33B	2.58B
Long-Term Leases	302M	267M	266M	241M	208M
Unearned Revenue Non Current	157M	160M	168M	181M	-
Other Non Current Liabilities	157B	145B	158B	161B	164B
Total Liabilities	170B	155B	170B	176B	184B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	9.22B	9.52B	9.82B	10.14B	10.38B
Retained Earnings	17.52B	19.53B	21.9B	24.71B	27.66B
Treasury Stock	-21.07B	-23.09B	-25.24B	-27.72B	-30.6B
Comprehensive Income and Other	3M	-2.35B	-1.77B	-1.91B	-892M
Total Common Equity	5.68B	3.61B	4.73B	5.23B	6.55B
Total Equity	5.68B	3.61B	4.73B	5.23B	6.55B
Total Liabilities And Equity	176B	158B	175B	181B	191B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	111M	105M	100M	96.12M	91.18M
ECS Total Common Shares Outstanding	111M	105M	100M	96.17M	91.26M
Book Value / Share	51.28	34.32	47.21	54.36	71.76
Tangible Book Value	3.12B	1.13B	2.11B	2.66B	3.95B
Tangible Book Value Per Share	28.12	10.71	21.02	27.62	43.27
Total Debt	3.84B	3.69B	4.23B	3.68B	3.77B
Net Debt	-4.54B	-3.54B	-3.43B	-4.47B	-6.32B
Debt Equivalent of Unfunded Proj. Benefit Obligation	232M	114M	63M	12M	-41M
Debt Equivalent Oper. Leases	456M	488M	440M	488M	496M
Account Code - Inventory Valuation	3	3	3	3	3
Full Time Employees	12K	13.5K	13.8K	13.6K	13.6K
Accumulated Allowance for Doubtful Accounts (Supple)	55M	75M	81M	69M	71M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	2.76B	2.56B	2.56B	3.4B	3.56B
Depreciation & Amortization - CF	64M	-85M	-206M	-215M	-154M
Amortization of Goodwill and Intangible Assets - (CF)	34M	45M	52M	56M	61M
Depreciation & Amortization, Total	98M	-40M	-154M	-159M	-93M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-647M	32M	61M	-5M	3M
Asset Writedown & Restructuring Costs	4M	98M	-16M	9M	19M
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	75M	36M	27M	19M	8M
Stock-Based Compensation (CF)	152M	170M	187M	193M	206M
Other Operating Activities, Total	-87M	-4M	18M	125M	157M
Change In Accounts Receivable	-520M	44M	276M	215M	-159M
Change In Accounts Payable	300M	-219M	354M	105M	261M
Change In Income Taxes	-308M	116M	-387M	200M	-108M
Change In Deferred Taxes	4M	4M	-	-	-
Change in Other Net Operating Assets	1.49B	1.61B	1.76B	2.49B	4.47B
Cash from Operations	3.32B	4.41B	4.68B	6.6B	8.32B
Capital Expenditure	-120M	-182M	-184M	-176M	-162M
Cash Acquisitions	-576M	34M	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-3.14B	-13.46B	-9.48B	-555M	-855M
Net (Increase) Decrease in Loans Originated / Sold - Investing	36M	-38M	-132M	-238M	-473M
Other Investing Activities, Total	-579M	59M	539M	418M	-38M
Cash from Investing	-4.38B	-13.58B	-9.26B	-551M	-1.53B
Long-Term Debt Issued, Total	1.76B	836M	1.34B	1.27B	1.86B
Total Debt Issued	1.76B	836M	1.34B	1.27B	1.86B
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-1.15B	-514M	-1.04B	-1.56B	-1.43B
Total Debt Repaid	-1.15B	-514M	-1.04B	-1.56B	-1.43B
Issuance of Common Stock	1M	-	-	-	-
Repurchase of Common Stock	-2.03B	-1.98B	-2.13B	-2.45B	-2.91B
Common Dividends Paid	-511M	-534M	-550M	-574M	-596M
Common & Preferred Stock Dividends Paid	-511M	-534M	-550M	-574M	-596M
Other Financing Activities, Total	3.65B	10.62B	6.79B	-1.85B	-2.08B
Cash from Financing	1.72B	8.43B	4.41B	-5.16B	-5.16B
Foreign Exchange Rate Adjustments	-2M	-68M	31M	-10M	31M
Net Change in Cash	666M	-814M	-135M	869M	1.67B
Supplemental Items
Cash Interest Paid	203M	227M	859M	1.01B	752M
Cash Income Tax Paid (Refund)	986M	500M	1.04B	496M	885M
Levered Free Cash Flow	-6.34B	1.32B	4.15B	2.84B	3.57B
Unlevered Free Cash Flow	-5.84B	1.9B	5.11B	3.84B	4.34B
Change In Net Working Capital	8.68B	695M	-1.69B	111M	-134M
Net Debt Issued / Repaid	609M	322M	300M	-292M	429M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.53	1.56	2.1	2.26	2.27
Return on Total Capital	26.95	30.51	42.64	45.18	43.88
Return On Equity %	47.78	53.57	59.92	68.31	60.51
Return on Common Equity	47.78	53.57	59.92	68.31	60.51
Margin Analysis
Gross Profit Margin %	56.45	54.67	58.54	57.8	56.18
SG&A Margin	25.31	25.6	23.66	21.77	20.49
EBITDA Margin %	31.86	29.76	-	-	-
EBITA Margin %	31.38	29.39	35.2	36.34	36.02
EBIT Margin %	31.13	29.07	34.87	36.03	35.69
Income From Continuing Operations Margin %	20.53	17.84	15.88	18.97	18.84
Net Income Margin %	20.53	17.84	15.88	18.97	18.84
Net Avail. For Common Margin %	20.53	17.84	15.88	18.97	18.84
Normalized Net Income Margin	15.72	14.08	12.8	14.88	14.89
Levered Free Cash Flow Margin	-47.18	9.18	25.75	15.83	18.87
Unlevered Free Cash Flow Margin	-43.45	13.27	31.73	21.43	22.94
Asset Turnover
Asset Turnover	0.08	0.09	0.1	0.1	0.1
Fixed Assets Turnover	15.1	15.55	17.09	18.43	19.36
Receivables Turnover (Average Receivables)	0.95	0.77	0.81	0.93	1.01
Short Term Liquidity
Current Ratio	3.22	3.86	3.13	2.6	2.29
Quick Ratio	2.49	3.15	2.46	1.78	1.46
Operating Cash Flow to Current Liabilities	0.34	0.6	0.51	0.52	0.49
Days Sales Outstanding (Average Receivables)	385.34	471.42	452.28	392.94	362.12
Average Days Payable Outstanding	141.04	133.84	132.49	128.38	125.23
Long Term Solvency
Total Debt/Equity	67.56	102.24	89.45	70.39	57.6
Total Debt / Total Capital	40.32	50.55	47.22	41.31	36.55
LT Debt/Equity	54.42	63.88	65.45	49.23	42.53
Long-Term Debt / Total Capital	32.48	31.59	34.55	28.9	26.98
Total Liabilities / Total Assets	96.77	97.72	97.3	97.12	96.57
EBIT / Interest Expense	5.21	4.44	3.65	4.02	5.48
EBITDA / Interest Expense	5.4	4.61	3.68	4.06	5.53
(EBITDA - Capex) / Interest Expense	5.26	4.42	3.56	3.95	5.4
Total Debt / EBITDA	0.89	0.85	0.75	0.56	0.55
Net Debt / EBITDA	-1.05	-0.82	-0.61	-0.69	-0.93
Total Debt / (EBITDA - Capex)	0.91	0.89	0.77	0.58	0.57
Net Debt / (EBITDA - Capex)	-1.08	-0.85	-0.63	-0.7	-0.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.42	6.72	12.29	11.37	5.49
Gross Profit, 1 Yr. Growth %	30.47	3.37	5.81	9.97	2.55
EBITDA, 1 Yr. Growth %	47.33	-0.33	-	-	-
EBITA, 1 Yr. Growth %	54.49	-0.07	7.35	14.99	4.56
EBIT, 1 Yr. Growth %	55	-0.33	7.28	15.05	4.52
Earnings From Cont. Operations, 1 Yr. Growth %	79.92	-7.28	-18.83	33.06	4.76
Net Income, 1 Yr. Growth %	79.92	-7.28	-18.83	33.06	4.76
Normalized Net Income, 1 Yr. Growth %	84.31	-4.44	-17.21	29.46	5.55
Diluted EPS Before Extra, 1 Yr. Growth %	88.52	-2.13	-14.4	39.39	9.77
Accounts Receivable, 1 Yr. Growth %	107.25	-2.63	-3.32	-4.02	3.1
Net Property, Plant and Equip., 1 Yr. Growth %	6.74	0.76	3.46	3.03	-2.03
Total Assets, 1 Yr. Growth %	6.09	-9.92	10.29	3.55	5.24
Tangible Book Value, 1 Yr. Growth %	-19.54	-66.56	59.79	26.12	48.68
Common Equity, 1 Yr. Growth %	-3.1	-39.19	24.35	10.55	25.27
Cash From Operations, 1 Yr. Growth %	-28.08	32.54	6.31	40.77	26.2
Capital Expenditures, 1 Yr. Growth %	-18.37	51.67	1.1	-4.35	-7.95
Levered Free Cash Flow, 1 Yr. Growth %	-476.2	-120.78	95.98	-31.41	18.25
Unlevered Free Cash Flow, 1 Yr. Growth %	-362.31	-132.63	89.01	-24.65	7.87
Dividend Per Share, 1 Yr. Growth %	8.31	10.16	8.61	9.25	8.46
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.12	9.53	9.64	11.83	8.39
Gross Profit, 2 Yr. CAGR %	9.53	16.13	6.82	7.87	6.19
EBITDA, 2 Yr. CAGR %	15.06	21.18	-	-	-
EBITA, 2 Yr. CAGR %	16.87	24.25	7.64	11.1	9.65
EBIT, 2 Yr. CAGR %	17.1	24.29	7.52	11.1	9.66
Earnings From Cont. Operations, 2 Yr. CAGR %	20.75	29.16	-13.51	3.92	18.07
Net Income, 2 Yr. CAGR %	20.75	29.16	-13.51	3.92	18.07
Normalized Net Income, 2 Yr. CAGR %	28.98	32.71	-11.59	3.53	16.9
Diluted EPS Before Extra, 2 Yr. CAGR %	28.54	35.83	-8.76	9.23	23.7
Accounts Receivable, 2 Yr. CAGR %	50	42.06	-3.54	-3.67	-0.53
Net Property, Plant and Equip., 2 Yr. CAGR %	2.37	3.71	2.1	3.24	0.47
Total Assets, 2 Yr. CAGR %	7.66	-2.26	-0.2	6.86	4.39
Tangible Book Value, 2 Yr. CAGR %	-8.7	-46.04	-20.98	41.96	36.93
Common Equity, 2 Yr. CAGR %	-0.38	-21.53	-10.78	17.25	17.68
Cash From Operations, 2 Yr. CAGR %	19.18	-2.36	18.7	22.33	33.29
Capital Expenditures, 2 Yr. CAGR %	-8.39	11.27	23.83	-1.66	-6.17
Levered Free Cash Flow, 2 Yr. CAGR %	100.44	-11.61	-16.31	15.81	-7.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	62.36	-7.53	-2.9	19.23	-7.75
Dividend Per Share, 2 Yr. CAGR %	7.83	9.23	9.38	8.93	8.85
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.32	3.63	10.41	10.22	9.68
Gross Profit, 3 Yr. CAGR %	4.43	7.44	17.45	7.86	6.06
EBITDA, 3 Yr. CAGR %	4.91	9.69	-	-	-
EBITA, 3 Yr. CAGR %	6.01	10.92	27.53	10.04	8.88
EBIT, 3 Yr. CAGR %	6.03	10.97	27.63	9.98	8.86
Earnings From Cont. Operations, 3 Yr. CAGR %	9.57	10.57	18.55	-0.16	4.2
Net Income, 3 Yr. CAGR %	9.57	10.57	18.55	-0.16	4.2
Normalized Net Income, 3 Yr. CAGR %	10.55	16.71	21.56	0.39	4.2
Diluted EPS Before Extra, 3 Yr. CAGR %	17.44	17.38	24.79	5.09	9.41
Accounts Receivable, 3 Yr. CAGR %	37.95	29.88	24.47	-3.7	-1.46
Net Property, Plant and Equip., 3 Yr. CAGR %	13.11	1.83	3.62	2.41	1.45
Total Assets, 3 Yr. CAGR %	8.65	1.44	1.84	1.03	6.32
Tangible Book Value, 3 Yr. CAGR %	-17.68	-32.93	-18.39	-7.66	44.16
Common Equity, 3 Yr. CAGR %	0.58	-14.24	-6.94	-4.17	19.86
Cash From Operations, 3 Yr. CAGR %	8.59	23.48	0.44	25.64	23.61
Capital Expenditures, 3 Yr. CAGR %	-9.52	8.37	7.77	13.62	-3.81
Levered Free Cash Flow, 3 Yr. CAGR %	51.46	-5.86	34.97	-21.74	19.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	33.49	-4.93	31.88	-10.82	17.1
Dividend Per Share, 3 Yr. CAGR %	7.86	8.6	9.02	9.33	8.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.57	3.33	4.49	6.82	9.6
Gross Profit, 5 Yr. CAGR %	6.35	4.54	7.18	10.37	12.81
EBITDA, 5 Yr. CAGR %	9.15	4.91	-	-	-
EBITA, 5 Yr. CAGR %	10.64	5.99	9.85	16.09	20.05
EBIT, 5 Yr. CAGR %	10.7	5.94	9.84	16.17	20.11
Earnings From Cont. Operations, 5 Yr. CAGR %	16.02	11.57	4.03	12.43	18.36
Net Income, 5 Yr. CAGR %	16.02	11.57	4.03	12.43	18.36
Normalized Net Income, 5 Yr. CAGR %	15.95	7.86	5.66	15.98	19.67
Diluted EPS Before Extra, 5 Yr. CAGR %	24.11	18.98	10.8	18.88	24.35
Accounts Receivable, 5 Yr. CAGR %	25.05	22.32	19.56	14.98	13.8
Net Property, Plant and Equip., 5 Yr. CAGR %	8.65	8.15	8.57	2.39	2.35
Total Assets, 5 Yr. CAGR %	4.71	1.45	5.01	3.62	2.85
Tangible Book Value, 5 Yr. CAGR %	-13.11	-28.4	-17.73	-6.61	0.38
Common Equity, 5 Yr. CAGR %	-2.01	-9.63	-3.28	-1.81	2.22
Cash From Operations, 5 Yr. CAGR %	7.36	23.68	12.52	23.02	12.48
Capital Expenditures, 5 Yr. CAGR %	5.46	2.36	2.58	4.24	1.96
Levered Free Cash Flow, 5 Yr. CAGR %	38.99	5.15	17.83	12.44	16.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.72	3.62	15.77	11.63	14.27
Dividend Per Share, 5 Yr. CAGR %	8.69	8.54	8.47	8.73	8.96